À¯¹æ »ý°Ë ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)
Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»óǰÄÚµå
:
1537024
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 08¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 353 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ÃÖ±Ù ¼¼°è À¯¹æ »ý°Ë ½ÃÀå¿¡ ´ëÇÑ »ó¼¼ÇÑ Á¶»ç º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» ÅëÇØ ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
À¯¹æ »ý°Ë ½ÃÀå ±Ô¸ð(2024E) : 23¾ï ´Þ·¯
¿¹»ó ½ÃÀå °¡Ä¡(2033F) : 38¾ï ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2033³â CAGR) : 5.7%
À¯¹æ »ý°Ë ½ÃÀå - º¸°í¼ ¹üÀ§:
À¯¹æ »ý°Ë ½ÃÀå¿¡´Â °Ë»ç¸¦ À§ÇØ ÀÛÀº Á¶Á÷ »ùÇÃÀ» äÃëÇÏ¿© À¯¹æ¾ÏÀ» Áø´ÜÇϱâ À§ÇÑ ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡´Â ¾ÏÀÇ Á¶±â ¹ß°ß ¹× Áø´Ü¿¡ ÇʼöÀûÀÎ ¹Ù´Ã »ý°Ë, °³º¹ ¼ö¼ú »ý°Ë, Áø°ø º¸Á¶ »ý°Ë µî ´Ù¾çÇÑ À¯ÇüÀÇ À¯¹æ »ý°ËÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº º´¿ø, Áø´Ü¼¾ÅÍ, ¿Ü·¡ ¼ö¼ú¼¾ÅÍ µî ´Ù¾çÇÑ ºÎ¹®¿¡ ¼ºñ½º¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, Á÷ÆÇ ¹× ÀÇ·á¿ëǰ ÆÇ¸ÅÁ¡ µî ´Ù¾çÇÑ Ã¤³ÎÀ» ÅëÇØ À¯ÅëµÇ°í ÀÖ½À´Ï´Ù. À¯¹æ¾Ï °ËÁø¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, À¯¹æ¾Ï À¯º´·ü Áõ°¡, »ý°Ë ±â¼úÀÇ ±â¼úÀû Áøº¸ µîÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
À¯¹æ »ý°Ë ¼¼°è ½ÃÀåÀ» À̲ô´Â ¸î °¡Áö ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î À¯¹æ¾Ï ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó À¯¹æ »ý°Ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »ý°Ë Àåºñ¿Í ½Ã¼úÀÇ ±â¼úÀû ¹ßÀüÀº ÀÌ·¯ÇÑ ½Ã¼úÀÇ Á¤È®¼º°ú ÆíÀǼºÀ» Çâ»ó½ÃÄÑ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯¹æ¾Ï Á¶±â °ËÁø ¹× Áø´Ü¿¡ ´ëÇÑ Àνİú ³ë·ÂÀÌ ³ô¾ÆÁö¸é¼ À¯¹æ¾Ï »ý°Ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ¿¹¹æÀû °Ç° °ü¸®¿¡ ´ëÇÑ °ü½Éµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¾ïÁ¦¿äÀÎ:
À¯¹æ »ý°Ë ½ÃÀåÀº À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í °í±Þ »ý°Ë Àåºñ ¹× ½Ã¼úÀÇ ³ôÀº ºñ¿ë, ºÒÆíÇÔ ¹× °¨¿° À§Çè°ú °°Àº ÀáÀçÀû ¹®Á¦¿Í °ü·ÃµÈ °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á±â±â ¾ÈÀü¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦¿Í ÁøÈÇÏ´Â ÀÓ»óÀû ¿ä±¸¿¡ ´ëÀÀÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÇ Çʿ伺¿¡ ÀÇÇØ ½ÃÀåµµ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ°í °æÀï·ÂÀ» À¯ÁöÇϱâ À§Çؼ´Â È¿°úÀûÀΠȯÀÚ ±³À°, °æÀï·Â ÀÖ´Â °¡°Ý Ã¥Á¤, ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù.
½ÃÀå ±âȸ:
½ÃÀå °³Ã´Àº Á¤È®ÇÏ°í Æí¾ÈÇÑ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ °íǰÁúÀÇ ÃÖ¼Òħ½ÀÀû »ý°Ë Àåºñ¸¦ °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë´Â ½ÃÀå ¼ºÀåÀ» À§ÇÑ »õ·Î¿î ä³ÎÀ» Á¦°øÇÏ¿© ±â¾÷ÀÌ ´õ ¸¹Àº »ç¶÷µé¿¡°Ô ´Ù°¡°¥ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. µµ½ÃÈÀÇ ÁøÀü°ú °Ç°¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ À¯¹æ »ý°Ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, ½Å±â¼ú¿¡ ´ëÇÑ ÅõÀÚ, Çõ½ÅÀûÀÎ »ý°Ë ÀåºñÀÇ µµÀÔÀº »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.
º» º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé
¼¼°è À¯¹æ »ý°Ë ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
´Ù¾çÇÑ È¯°æ¿¡¼ ¾î¶² Á¾·ùÀÇ À¯¹æ »ý°Ë¼ú°ú ¿ëµµ°¡ äÅÃÀ» ÁÖµµÇϰí Àִ°¡?
±â¼úÀÇ ¹ßÀüÀº À¯¹æ »ý°Ë ½ÃÀåÀÇ °æÀï »óȲ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ½À´Ï±î?
À¯¹æ »ý°Ë ½ÃÀåÀÇ ÁÖ¿ä Ç÷¹À̾î´Â ´©±¸ÀÌ¸ç °æÀïÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇϰí Àִ°¡?
¼¼°è À¯¹æ »ý°Ë ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ÇâÈÄ Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ºÐ·ù
½ÃÀå Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
Æ÷ÇÔ°ú ¹èÁ¦
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ
Á¦4Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®
Á¦Ç° ä¿ë/»ç¿ë »óȲ ºÐ¼®
Á¦Á¶¾÷üº° ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·«
±ÔÁ¦ ½Ã³ª¸®¿À
PESTLE ºÐ¼®
Porters ºÐ¼®
½ÅÁ¦Ç° ¹ß¸Å
±â¼ú Æò°¡
Á¦5Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦6Àå COVID-19 À§±â ºÐ¼®
COVID-19¿Í ¿µÇ⠺м®
Á¦Ç°º° ¸ÅÃâ
ÀûÀÀÁõº° ¸ÅÃâ
ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ
±¹°¡º° ¸ÅÃâ
2024³â ½ÃÀå ½Ã³ª¸®¿À
Á¦7Àå ¼¼°è ½ÃÀå ¼ö¿ä(¼ö·®) ºÐ¼®
½ÃÀå(¼ö·®) ºÐ¼®, 2019-2023³â
½ÃÀå(¼ö·®) ¿¹Ãø, 2024-2033³â
Á¦8Àå ¼¼°è ½ÃÀå - °¡°Ý ºÐ¼®
Á¦Ç°º° Áö¿ªº° °¡°Ý ºÐ¼®
°¡°Ý ³»¿ª
Á¦Á¶¾÷ü ·¹º§ °¡°Ý ¼³Á¤
À¯Åë¾÷ü ·¹º§ °¡°Ý ¼³Á¤
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
°¡°Ý ¼³Á¤ °¡Á¤
Á¦9Àå ¼¼°è ½ÃÀå ¼ö¿ä(±Ý¾×) ºÐ¼®
½ÃÀå(±Ý¾×) ºÐ¼®, 2019-2023³â
½ÃÀå(±Ý¾×) ¿¹Ãø, 2024-2033³â
Àü³âºñ ¼ºÀå µ¿Ç⠺м®
Àý´ëÀû ¼öÀÍ ±âȸ
Á¦10Àå Á¦Ç°º° : ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ¼®°ú ¿¹Ãø, 2024-2033³â
»ý°Ëħ
MRI °¡ÀÌµå »ý°Ë ½Ã½ºÅÛ
ÃÊÀ½ÆÄ À¯µµÇÏ À¯¹æ »ý°Ë ½Ã½ºÅÛ
2Â÷¿ø(2D) ¸¾¸ð±×·¡ÇÇ ÃÊÀ½ÆÄ ½ºÄµ ½Ã½ºÅÛ
3Â÷¿ø(3D) B¸ðµå ¸¾¸ð±×·¡ÇÇ ÃÊÀ½ÆÄ ½ºÄµ ½Ã½ºÅÛ
ÈíÀÎ º¸Á¶ ±â±â(VAD)
°¡À̵å¿ÍÀ̾î(·ÎÄø®Á¦ÀÌ¼Ç ¿ÍÀ̾î)
À¯¹æ »ý°Ë ¸¶Ä¿
Á¦Ç°º° ½ÃÀå ¸Å·Â ºÐ¼®
Á¦11Àå ÀûÀÀÁõº° : ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(±Ý¾×) ¼®°ú ¿¹Ãø, 2024-2033³â
º¹ÇÕ ³¶Á¾
°íÇü µ¢¾î¸®
Àǽɽº·¯¿î °íÇü µ¢¾î¸®(¼¶À¯¼±Á¾)
Àǽɽº·¯¿î ¹Ì¼¼ ¼®È¸È
ÀûÀÀÁõº° ½ÃÀå ¸Å·Â ºÐ¼®
Á¦12Àå ÃÖÁ¾»ç¿ëÀÚº° : ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(±Ý¾×) ¼®°ú ¿¹Ãø, 2024-2033³â
º´¿ø
Àü¹® Ŭ¸®´Ð
¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
¾Ï Á¶»ç ±â°ü
ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ¸Å·Â ºÐ¼®
Á¦13Àå Áö¿ªº° : ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³
½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
³²¾Æ½Ã¾Æ
µ¿¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
Áö¿ªº° ½ÃÀå ¸Å·Â ºÐ¼®
Á¦14Àå ºÏ¹Ì ½ÃÀå ºÐ¼®
Á¦15Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®
Á¦16Àå À¯·´ ½ÃÀå ºÐ¼®
Á¦17Àå ³²¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®
Á¦18Àå µ¿¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®
Á¦19Àå ¿À¼¼¾Æ´Ï¾Æ ½ÃÀå ºÐ¼®
Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®
Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®
±â¾÷ °èÃþº° ½ÃÀå ºÐ¼®
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(%)
½ÃÀå ÀÔÁö ºÐ¼®
Á¦22Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ ºê·£µù°ú ÇÁ·Î¸ð¼Ç Àü·«
ÁÖ¿ä °³¹ß ºÐ¼®
°æÀï »ó¼¼
Argon Medical Devices
Becton Dickinson and Company
CR Bard, Inc.
Cook Medical Inc.
Devicor Medical Products, Inc.
F. Hoffmann-La Roche Ltd.
GE Healthcare
Hologic, Inc.
Leica Biosystems
Medax Srl Unipersonale
Planmed Oy
Scion Medical Technologies, LLC
Siemens Healthineer
Á¦23Àå »ç¿ëµÇ´Â °¡Á¤°ú µÎ¹®ÀÚ¾î
Á¦24Àå Á¶»ç ¹æ¹ý
ksm
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently published a detailed report on the global Breast Biopsy Market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.
Key Insights:
Breast Biopsy Market Size (2024E): USD 2.3 Bn
Projected Market Value (2033F): USD 3.8 Bn
Global Market Growth Rate (CAGR 2024 to 2033): 5.7%
Breast Biopsy Market - Report Scope:
The Breast Biopsy Market encompasses a variety of products designed to diagnose breast cancer by removing a small tissue sample for examination. This market includes different types of breast biopsy procedures, such as needle biopsy, open surgical biopsy, and vacuum-assisted biopsy, which are essential for early cancer detection and diagnosis. The market serves diverse segments, including hospitals, diagnostic centers, and ambulatory surgical centers, distributed through various channels like direct sales and medical supply distributors. Growth is driven by increasing awareness of breast cancer screening, rising prevalence of breast cancer, and technological advancements in biopsy techniques.
Market Growth Drivers:
Several key factors drive the global Breast Biopsy Market. The rising incidence of breast cancer globally boosts the demand for breast biopsy procedures. Technological advancements in biopsy devices and techniques enhance the accuracy and comfort of these procedures, fueling market expansion. Additionally, the growing awareness and initiatives for early breast cancer screening and diagnosis drive the demand for breast biopsy. Increased healthcare expenditure and a focus on preventive health measures also contribute to market growth.
Market Restraints:
Despite promising growth prospects, the Breast Biopsy Market faces challenges related to the high cost of advanced biopsy devices and procedures and potential issues associated with their use, such as discomfort and risk of infection. The market is also impacted by the presence of stringent regulations on medical device safety and the need for continuous innovation to meet evolving clinical needs. Effective patient education, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.
Market Opportunities:
The market presents significant opportunities driven by the rising trend of early cancer detection and increasing awareness about the benefits of breast cancer screening.The development of high-quality and minimally invasive biopsy devices caters to the growing demand for accurate and comfortable diagnostic solutions. The expansion of healthcare infrastructure in emerging economies provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious individuals drive the demand for breast biopsy procedures. Strategic partnerships, investments in new technologies, and the introduction of innovative biopsy devices are essential for capitalizing on emerging opportunities and maintaining market leadership.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the Breast Biopsy Market globally?
Which types and applications of breast biopsy procedures are leading the adoption in various settings?
How are technological advancements influencing the competitive landscape of the Breast Biopsy Market?
Who are the key players in the Breast Biopsy Market, and what strategies are they employing to stay competitive?
What are the emerging trends and future prospects in the global Breast Biopsy Market?
Competitive Intelligence and Business Strategy:
Leading players in the global Breast Biopsy Market, including Hologic, Inc., Becton, Dickinson and Company, and Leica Biosystems, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced biopsy devices and techniques, such as vacuum-assisted and stereotactic biopsy systems. Collaborations with healthcare providers, research institutions, and medical device distributors facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Breast Biopsy Market landscape.
Key Companies Profiled:
Argon Medical
Becton Dickinson and Company
C.R. Bard, Inc.
Cook Medical Inc.
Devicor Medical Products, Inc.
F. Hoffmann-La Roche Ltd.,
GE Healthcare
Hologic, Inc.
Leica Biosystems
Medax Srl Unipersonale
Planmed Oy
Scion Medical Technologies, LLC
Siemens Healthineers
Hikma Pharmaceuticals
Incytes
Breast Biopsy Market Industry Segmentation
By Product:
Biopsy Needles
MRI-Guide Biopsy Systems
Ultrasound Guided Breast Biopsy Systems
Vacuum-Assisted Devices (VAD)
Guide Wire (Localization Wire)
Breast Biopsy Markers
Indication:
Complex Cysts
Solid Mass
Suspicious Solid Mass (Fibroadenoma)
Suspicious Micro-calcifications
End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Key Promotional Strategies, by Manufacturers
4.3. Regulatory Scenario
4.4. PESTLE Analysis
4.5. Porter's Analysis
4.6. New Product Launches
4.7. Technology Assessment
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising demand for Breast Biopsy Devices
5.2.2. Cost of Procedures
5.2.3. Adoption Rate
5.2.4. Increase in Research and Development
5.2.5. Availability of Product
5.2.6. Strategic Mergers and Collaborations Among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. Revenue by Product
6.1.2. Revenue By Indication
6.1.3. Revenue By End User
6.1.4. Revenue By Country
6.2. 2024 Market Scenario
7. Global Market Demand (in Volume Units) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Volume (Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (units) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market- Pricing Analysis
8.1. Regional Pricing Analysis by Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) & Volume (Units) Analysis by Product, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
10.3.1. Biopsy Needle
10.3.1.1. Core Needles
10.3.1.2. Fine Aspiration Needles
10.3.2. MRI-Guide Biopsy Systems
10.3.3. Ultrasound Guided Breast Biopsy Systems
10.3.3.1. Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
10.3.3.2. Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
10.3.4. Vacuum-Assisted Device (VAD)
10.3.5. Guide Wire (Localization Wire)
10.3.6. Breast Biopsy Marker
10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis by Indication, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
11.3.1. Complex Cyst
11.3.2. Solid Mass
11.3.3. Suspicious Solid Mass (Fibroadenoma)
11.3.4. Suspicious Micro Calcifications
11.4. Market Attractiveness Analysis by Indication
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Ambulatory Surgical Centers
12.3.4. Cancer Research Institutes
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2023
13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Region, 2024-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa(MEA)
13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Indication
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. U.S. Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Indication
14.8.1.2.3. By End User
14.8.2. Canada Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Indication
14.8.2.2.3. By End-User
15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast recast by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Indication
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Brazil Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Indication
15.8.1.2.3. By End User
15.8.2. Mexico Market
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Indication
15.8.2.2.3. By End User
15.8.3. Argentina Market
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Indication
15.8.3.2.3. By End User
16. Europe Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Nordic Countries
16.3.1.8. Russia
16.3.1.9. Rest of Europe
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Indication
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Germany Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Indication
16.8.1.2.3. By End User
16.8.2. Italy Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Indication
16.8.2.2.3. By End User
16.8.3. France Market
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Indication
16.8.3.2.3. By End User
16.8.4. U.K. Market
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Indication
16.8.4.2.3. By End User
16.8.5. Spain Market
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Indication
16.8.5.2.3. By End User
16.8.6. BENELUX Market
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Indication
16.8.6.2.3. By End User
16.8.7. Nordic Countries Market
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Indication
16.8.7.2.3. By End User
16.8.8. Russia Market
16.8.8.1. Introduction
16.8.8.2. Market Analysis and Forecast by Market Taxonomy
16.8.8.2.1. By Product
16.8.8.2.2. By Indication
16.8.8.2.3. By End User
17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Indication
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. India Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Indication
17.8.1.2.3. By End User
17.8.2. Thailand Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Indication
17.8.2.2.3. By End User
17.8.3. Indonesia Market
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Indication
17.8.3.2.3. By End User
17.8.4. Malaysia Market
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Indication
17.8.4.2.3. By End User
18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Indication
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. China Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Indication
18.8.1.2.3. By End User
18.8.2. Japan Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Indication
18.8.2.2.3. By End User
18.8.3. South Korea Market
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Indication
18.8.3.2.3. By End User
19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Indication
19.4.4. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. Australia Market
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Indication
19.8.1.2.3. By End User
19.8.2. New Zealand Market
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Indication
19.8.2.2.3. By End User
20. Middle East & Africa Market Analysis 2019-2023and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkiye
20.3.1.3. South Africa
20.3.1.4. North Africa
20.3.1.5. Rest of MEA
20.3.2. By Product
20.3.3. By Indication
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Indication
20.4.4. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Market
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Indication
20.8.1.2.3. By End User
20.8.2. Turkiye Market
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Indication
20.8.2.2.3. By End User
20.8.3. South Africa Market
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Indication
20.8.3.2.3. By End User
20.8.4. North Africa Market
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By Indication
20.8.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players (%)
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Branding and Promotional Strategies, by Key Players
22.3. Key Development Analysis
22.4. Competition Deep Dive
22.4.1. Argon Medical Devices
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Key Financial
22.4.1.4. Sales Footprint
22.4.1.5. SWOT Analysis
22.4.1.6. Strategy Overview
22.4.1.6.1. Marketing Strategies
22.4.1.6.2. Product Strategies
22.4.1.6.3. Channel Strategies
22.4.2. Becton Dickinson and Company
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Key Financial
22.4.2.4. Sales Footprint
22.4.2.5. SWOT Analysis
22.4.2.6. Strategy Overview
22.4.2.6.1. Marketing Strategies
22.4.2.6.2. Product Strategies
22.4.2.6.3. Channel Strategies
22.4.3. C. R. Bard, Inc.
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Key Financial
22.4.3.4. Sales Footprint
22.4.3.5. SWOT Analysis
22.4.3.6. Strategy Overview
22.4.3.6.1. Marketing Strategies
22.4.3.6.2. Product Strategies
22.4.3.6.3. Channel Strategies
22.4.4. Cook Medical Inc.
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Key Financial
22.4.4.4. Sales Footprint
22.4.4.5. SWOT Analysis
22.4.4.6. Strategy Overview
22.4.4.6.1. Marketing Strategies
22.4.4.6.2. Product Strategies
22.4.4.6.3. Channel Strategies
22.4.5. Devicor Medical Products, Inc.
22.4.5.1. Overview
22.4.5.2. Product Portfolio
22.4.5.3. Key Financial
22.4.5.4. Sales Footprint
22.4.5.5. SWOT Analysis
22.4.5.6. Strategy Overview
22.4.5.6.1. Marketing Strategies
22.4.5.6.2. Product Strategies
22.4.5.6.3. Channel Strategies
22.4.6. F. Hoffmann-La Roche Ltd.
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Key Financial
22.4.6.4. Sales Footprint
22.4.6.5. SWOT Analysis
22.4.6.6. Strategy Overview
22.4.6.6.1. Marketing Strategies
22.4.6.6.2. Product Strategies
22.4.6.6.3. Channel Strategies
22.4.7. GE Healthcare
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Key Financial
22.4.7.4. Sales Footprint
22.4.7.5. SWOT Analysis
22.4.7.6. Strategy Overview
22.4.7.6.1. Marketing Strategies
22.4.7.6.2. Product Strategies
22.4.7.6.3. Channel Strategies
22.4.8. Hologic, Inc.
22.4.8.1. Overview
22.4.8.2. Product Portfolio
22.4.8.3. Key Financial
22.4.8.4. Sales Footprint
22.4.8.5. SWOT Analysis
22.4.8.6. Strategy Overview
22.4.8.6.1. Marketing Strategies
22.4.8.6.2. Product Strategies
22.4.8.6.3. Channel Strategies
22.4.9. Leica Biosystems
22.4.9.1. Overview
22.4.9.2. Product Portfolio
22.4.9.3. Key Financial
22.4.9.4. Sales Footprint
22.4.9.5. SWOT Analysis
22.4.9.6. Strategy Overview
22.4.9.6.1. Marketing Strategies
22.4.9.6.2. Product Strategies
22.4.9.6.3. Channel Strategies
22.4.10. Medax Srl Unipersonale
22.4.10.1. Overview
22.4.10.2. Product Portfolio
22.4.10.3. Key Financial
22.4.10.4. Sales Footprint
22.4.10.5. SWOT Analysis
22.4.10.6. Strategy Overview
22.4.10.6.1. Marketing Strategies
22.4.10.6.2. Product Strategies
22.4.10.6.3. Channel Strategies
22.4.11. Planmed Oy
22.4.11.1. Overview
22.4.11.2. Product Portfolio
22.4.11.3. Key Financial
22.4.11.4. Sales Footprint
22.4.11.5. SWOT Analysis
22.4.11.6. Strategy Overview
22.4.11.6.1. Marketing Strategies
22.4.11.6.2. Product Strategies
22.4.11.6.3. Channel Strategies
22.4.12. Scion Medical Technologies, LLC
22.4.12.1. Overview
22.4.12.2. Product Portfolio
22.4.12.3. Key Financial
22.4.12.4. Sales Footprint
22.4.12.5. SWOT Analysis
22.4.12.6. Strategy Overview
22.4.12.6.1. Marketing Strategies
22.4.12.6.2. Product Strategies
22.4.12.6.3. Channel Strategies
22.4.13. Siemens Healthineer
22.4.13.1. Overview
22.4.13.2. Product Portfolio
22.4.13.3. Key Financial
22.4.13.4. Sales Footprint
22.4.13.5. SWOT Analysis
22.4.13.6. Strategy Overview
22.4.13.6.1. Marketing Strategies
22.4.13.6.2. Product Strategies
22.4.13.6.3. Channel Strategies
23. Assumptions and Acronyms Used
24. Research Methodology
°ü·ÃÀÚ·á